Long-Term Care Providers Agree to End Automatic Opioid Rejections

SHARE NOW

HARRISBURG, Pa. — Twelve companies operating more than 200 nursing homes and other long-term-care facilities have agreed to change admission practices involving people who use prescribed opioids, Pennsylvania Attorney General Dave Sunday announced.

The companies will assess prospective residents individually instead of automatically denying admission because of medication prescribed to treat a disability. The commitments cover facilities in Pennsylvania and elsewhere in the country.

The attorney general’s office began its investigation after a 2024 complaint involving a Westmoreland County woman. According to the office, the woman’s mother had used methadone under a physician’s care for chronic pain related to fibromyalgia and Raynaud’s syndrome.

After the woman suffered a broken hip, hospitals tried to transfer her to a long-term rehabilitation facility. The complaint alleged that multiple facilities would not accept her because she took methadone. The attorney general’s Civil Rights Enforcement Section then reviewed the admission policies and practices of providers named in the complaint.

The Americans with Disabilities Act and Pennsylvania Human Relations Act prohibit disability discrimination in covered public accommodations, including skilled nursing and rehabilitation facilities. The attorney general’s office says those protections generally bar blanket medication-based policies and require individualized consideration and reasonable modifications unless a direct safety threat or fundamental change in services would result.

The agreements require the participating providers to replace automatic rejection practices with case-by-case assessments for applicants who rely on prescribed opioids or other medication to treat disabilities.